Investigating the pharmaceutical industry’s drug patenting practices
Five Patent Predictions for 2025
The Year in Patent Reform
Why Current Legislation to Prevent Patent Thickets Are a Good Start — But Not Enough
The Senate HELP Committee Takes Aim at Drug Patent Abuse
Why Patent Reform Is the One Thing Democrats and Republicans Are Agreeing On
Patent Abuse is Front-Page News
Blueprint to Address Patent Thickets, Improve Competition, and Lower Prescription Drug Prices
How Egregious Orange Book Manipulation Extended an Insulin Monopoly
Our New Study: The Burden of Patent Thickets